ING Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.41M | Sell |
|
|||||
|
2025
Q2 | $11.6M | Buy |
|
|||||
|
2025
Q1 | $12.9M | Sell |
|
|||||
|
2024
Q4 | $10.9M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.12M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $360K | Sell |
|
|||||
|
2022
Q4 | $20.8M | Buy |
|
|||||
|
2022
Q3 | $17.1M | Sell |
|
|||||
|
2022
Q2 | $21.9M | Buy |
|
|||||
|
2022
Q1 | $18.9M | Buy |
|
|||||
|
2021
Q4 | $14.7M | Buy |
|
|||||
|
2021
Q3 | $7.63M | Buy |
|
|||||
|
2021
Q2 | $7.68M | Buy |
|
|||||
|
2021
Q1 | $5.82M | Sell |
|
|||||
|
2020
Q4 | $5.3M | Buy |
|
|||||
|
2020
Q3 | $1.5M | Sell |
|
|||||
|
2020
Q2 | $19M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5.25M | Buy |
|
|||||
|
2019
Q3 | $3.83M | Sell |
|
|||||
|
2019
Q2 | $6.48M | Sell |
|
|||||
|
2019
Q1 | $11M | Buy |
|
|||||
|
2018
Q4 | $7.9M | Sell |
|
|||||
|
2018
Q3 | $9.76M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $5.74M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.9M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $3.24M | Buy |
|
|||||
|
2016
Q3 | $1.36M | Buy |
|
|||||
|
2016
Q2 | $489K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $29.5M | Sell |
|
|||||
|
2015
Q3 | $42.6M | Buy |
|
|||||
|
2015
Q2 | $49.3M | Buy |
|
|||||
|
2015
Q1 | $42.7M | Buy |
|
|||||
|
2014
Q4 | $33.9M | Buy |
|
|||||
|
2014
Q3 | $28.8M | Buy |
|
|||||
|
2014
Q2 | $23.9M | Sell |
|
|||||
|
2014
Q1 | $23.9M | Buy |
|
|||||
|
2013
Q4 | $20.5M | Buy |
|
|||||
|
2013
Q3 | $11.7M | Sell |
|
|||||
|
2013
Q2 | $33.4M | Buy |
|